Machine signal
Active cluster sell — 5 distinct insiders, $6.6M, window ends Sep 30, 2026.
Figures computed from official regulatory filings — .
Analysttarget 48.5 USD (+105%) · consensus 4.8/5 · 9 buy · 1 hold · 0 sell
Ownershipinsiders 0.79% · institutions 117.62% · short 12.4% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Mineralys Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. It is developing lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by dysregulated aldosterone, such as hypertension, chronic kidney disease, and obstructive sleep apnea. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. Mineralys Therapeutics, Inc. was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
19 buys126 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Congleton Jontrack record | Sell | $1.9M | SEC | ||
| Slingsby Brian Taylor | Sell | $3M | SEC | ||
| Warren Eric | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Warren Eric | Sell | $209.1K | SEC | ||
| Warren Eric | Exercise | $98.5K | SEC | ||
| Karydas Daphne | Sell | $85.7K | SEC | ||
| Karydas Daphne | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Karydas Daphne | Exercise | $36.1K | SEC | ||
| Warren Eric | Exercise | $98.5K | SEC | ||
| Warren Eric | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Warren Eric | Sell | $193.2K | SEC | ||
| Rodman David Malcom | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Rodman David Malcom | Sell | $58.8K | SEC | ||
| Ferguson James J. III | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Rodman David Malcom | Exercise | $34.7K | SEC | ||
| Ferguson James J. III | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Warren Eric | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Warren Eric | Sell | $199.9K | SEC | ||
| Warren Eric | Exercise | $98.5K | SEC | ||
| Rodman David Malcom | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
| Rodman David Malcom | Sell | $11K | SEC | ||
| Rodman David Malcom | Exercise | $6.4K | SEC | ||
| Congleton Jontrack record | Sell | $291.4K | SEC | ||
| Rodman David Malcom | Exercise | $6.9K | SEC | ||
| Rodman David Malcom | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |